Form 8-K - Current report:
SEC Accession No. 0001213900-26-055806
Filing Date
2026-05-13
Accepted
2026-05-13 16:14:12
Documents
13
Period of Report
2026-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0290436-8k_longeveron.htm   iXBRL 8-K 26568
2 PRESS RELEASE ISSUED BY THE COMPANY ON MAY 13, 2026 ea029043601ex99-1.htm EX-99.1 73884
3 GRAPHIC ea029043601_ex99-1img1.jpg GRAPHIC 9137
  Complete submission text file 0001213900-26-055806.txt   293927

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lgvn-20260513.xsd EX-101.SCH 3020
5 XBRL LABEL FILE lgvn-20260513_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE lgvn-20260513_pre.xml EX-101.PRE 22362
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0290436-8k_longeveron_htm.xml XML 3327
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 26973427
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)